Document is current
Any future updates will be listed below
-
Authors
Nakanishi, Miharu
Nakashima, Taeko
Miyamoto, Yuki
Yamasaki, Syudo
Nishida, Atsushi
-
Funding
Funding for this research was provided by:
Pfizer Health Research Foundation in Japan (2020-11, 2020-11)
Ministry of Health, Labour and Welfare (Ministry of Health, Labour Sciences research grant 19189500)
Japan Society for the Promotion of Science (JSPS KAKENHI JP21H03281, JSPS KAKENHI JP21H03281, JSPS KAKENHI JP21H03281, JSPS KAKENHI JP21H03281)
Japan Agency for Medical Research and Development (22579506)
Tokyo Metropolitan Institute of Medical Science
- License Information
-
More Information
Article History
Received: 31 January 2022
Accepted: 22 June 2022
First Online: 27 June 2022
Declarations
:
: The study protocol was approved by the Ethics Board of Tohoku University (number 2021–5-154) and the Tokyo Metropolitan Institute of Medical Science (number 20–55). All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from each participant.
: Not applicable.
: The authors declare that they have no conflicts of interest.
